UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions

Head & neck, 2019-10, Vol.41 (S1), p.4-18

2019

Volltextzugriff (PDF)

Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate-Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma

Molecular cancer therapeutics, 2017-07, Vol.16 (7), p.1421-1434

2017

Volltextzugriff (PDF)

Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: a real-world data analysis

BMC cancer, 2022-11, Vol.22 (1), p.1228-9, Article 1228

2022

Volltextzugriff (PDF)

Traits of Patients With Pituitary Tumors in Multiple Endocrine Neoplasia Type 1 and Comparing Different Mutation Status

The journal of clinical endocrinology and metabolism, 2023-11, Vol.108 (12), p.e1532-e1541

2023

Volltextzugriff (PDF)

Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma

Nature communications, 2023-05, Vol.14 (1), p.2781-2781, Article 2781

2023

Volltextzugriff (PDF)

Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma

Oncoimmunology, 2021-01, Vol.10 (1), p.1973710-1973710

2021

Volltextzugriff (PDF)

Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis

Clinical cancer research, 2022-04, Vol.28 (8), p.1560-1571

2022

Volltextzugriff (PDF)

A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing

Cancer immunology research, 2018-12, Vol.6 (12), p.1511-1523

2018

Volltextzugriff (PDF)

The branched N-glycan of PD-L1 predicts immunotherapy responses in patients with recurrent/metastatic HNSCC

Oncogenesis (New York, NY), 2024-10, Vol.13 (1), p.36-10, Article 36

2024

Volltextzugriff (PDF)

694 Possible immune-modulation of CDK4/6 inhibitors and clinical trial development in betel-nuts related head and neck squamous cell carcinoma in Taiwan

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A722-A722

2021

Volltextzugriff (PDF)

β-Catenin (CTNNB1) Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma

Oncology, 2014-01, Vol.87 (3), p.159-166

2014

Volltextzugriff (PDF)

EGFR inhibitors as the first-line systemic treatment for advanced non-small-cell lung cancer

Future oncology (London, England), 2013-07, Vol.9 (7), p.991-1003

2013

Volltextzugriff (PDF)

Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers

Supportive care in cancer, 2014-05, Vol.22 (5), p.1189-1197

2014

Volltextzugriff (PDF)

Aggressive revascularization of acute internal carotid artery occlusion in patients with NIHSS > 20 and poor collateral circulation: Preliminary report

International journal of cardiology, 2012-11, Vol.161 (2), p.97-102

2012

Volltextzugriff (PDF)

Primary pancreatic hepatoid carcinoma: A case report and literature review

Journal of cancer research and practice, 2023-07, Vol.10 (3), p.113

2023

Volltextzugriff (PDF)

Promising Response with PI3K Inhibitor for a Patient with Heavily Pretreated PIK3CA Mutation Head-and-Neck Cancer

Journal of cancer research and practice, 2023-04, Vol.10 (2), p.75-77

2023

Volltextzugriff (PDF)

A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study

The oncologist (Dayton, Ohio), 2024-06, Vol.29 (10), p.e1396-e1405

2024

Volltextzugriff (PDF)

Afatinib and pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma (ALPHA Study): A phase II study with biomarker analysis

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.6024-6024

2021

Volltextzugriff (PDF)

TCOG T5217 trial: A phase II randomized study of SLOG versus modified FOLFIRINOX as the first-line treatment in locally advanced or metastatic pancreatic ductal adenocarcinoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.4143-4143

2021

Volltextzugriff (PDF)

Abstract CT203: A phase II trial of ipilimumab in combination with nivolumab in EBV-associated advanced nasopharyngeal carcinoma (NCT03097939)

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.CT203-CT203

2020

Volltextzugriff (PDF)

A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.6025-6025

2021

Volltextzugriff (PDF)

Abstract 2656: Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.2656-2656

2012

Volltextzugriff (PDF)

[beta]-Catenin (CTNNB1) Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma

Oncology, 2014-07, Vol.87 (3), p.159-166

2014

Volltextzugriff (PDF)

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Journal for immunotherapy of cancer, 2016-11, Vol.4 (Suppl 1)

2016

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions

Histone Methyltransferase G9a Drives Chemotherapy Resistance by Regulating the Glutamate-Cysteine Ligase Catalytic Subunit in Head and Neck Squamous Cell Carcinoma

Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: a real-world data analysis

Traits of Patients With Pituitary Tumors in Multiple Endocrine Neoplasia Type 1 and Comparing Different Mutation Status

Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma

Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma

Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis

A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing

The branched N-glycan of PD-L1 predicts immunotherapy responses in patients with recurrent/metastatic HNSCC

694 Possible immune-modulation of CDK4/6 inhibitors and clinical trial development in betel-nuts related head and neck squamous cell carcinoma in Taiwan

β-Catenin (CTNNB1) Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma

EGFR inhibitors as the first-line systemic treatment for advanced non-small-cell lung cancer

Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers

Aggressive revascularization of acute internal carotid artery occlusion in patients with NIHSS > 20 and poor collateral circulation: Preliminary report

Primary pancreatic hepatoid carcinoma: A case report and literature review

Promising Response with PI3K Inhibitor for a Patient with Heavily Pretreated PIK3CA Mutation Head-and-Neck Cancer

A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study

Afatinib and pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma (ALPHA Study): A phase II study with biomarker analysis

TCOG T5217 trial: A phase II randomized study of SLOG versus modified FOLFIRINOX as the first-line treatment in locally advanced or metastatic pancreatic ductal adenocarcinoma

Abstract CT203: A phase II trial of ipilimumab in combination with nivolumab in EBV-associated advanced nasopharyngeal carcinoma (NCT03097939)

A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy

Abstract 2656: Predictors of bloodstream infection associated with permanently implantable venous port in solid cancer patients

[beta]-Catenin (CTNNB1) Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Suchergebnisse filtern